Effects of type 2 diabetes on the regulation of hepatic glucose metabolism

Journal of Investigative Medicine

Volumn 52, Issue 6, 2004, Pages 366-374

  Basu, Ananda ^a   Shah, Pankaj ^a   Nielsen, Michael ^b   Basu, Rita ^a   Rizza, Robert A ^a  

^a MAYO CLINIC   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Glucagon; Glucose effectiveness; Glucose production; Hepatic insulin action

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

CONFERENCE PAPER; FOOD INTAKE; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; INSULIN ACTION; INSULIN RELEASE; LIVER METABOLISM; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSTPRANDIAL STATE;

EID: 9244264963     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-52-06-30     Document Type: Conference Paper

References (35)

1. Butler PC, Rizza RA. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 1991;40:73-81.
2. Firth R, Bell P, Marsh M, Rizza RA. Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Diabetes 1987;36:1130-8.
3. Firth RG, Bell PM, Rizza RA. Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1986;314:1280-6.
4. Basu A, Caumo A, Bettini F, et al. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 1997;46:421-32.
5. Firth RG, Bell PM, Marsh HM, et al. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1986;77:1525-32.
6. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
7. Firth R, Bell P, Rizza R. Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism 1987;36:1091-5.
8. Butler PC, Kryshak EJ, Schwenk WF, et al. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by titrated nonglucose contaminants. Diabetes 1990;39:217-25.
9. Butler PC, Caumo A, Zerman A, et al. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol 1993;264:E548-69.
10. Steele R, Wall J, DeBodo R, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956;187:15-24.
11. Finegood DT, Bergman RN, Vranic M. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 1988;37:1025-34.
12. Allsop JR, Wolfe RR, Burke JF. The reliability of glucose appearance in vivo calculated from constant tracer infusions. Biochem J 1978;172:407-16.
13. Cobelli C, Toffolo G. Constant specific activity input allows reconstruction of endogenous glucose concentration in non-steady state. Am J Physiol 1990;258:E1037-40.
14. Cobelli C, Mari A, Ferrannini E. Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol 1987;252:E679-89.
15. Levy JC, Brown DR, Turner RC. Hepatic glucose output in humans measured with labeled glucose to reduce negative errors. Am J Physiol 1989;E531-40.
16. Molina JM, Baron AD, Edelman SV et al. Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol 1990;258:E16-23.
17. Hother-Nielsen O, Henriksen E, Staehr P, Beck-Nielsen H. Labelled glucose infusate technique in clamp studies. Is precise matching of glucose specific activity important? Endocrinol Metab 1995;2:275-87.
18. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 1987;36: 914-24.
19. Bergman RN, Hope ID, Yang YJ, et al. Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 1989;5:411-29.
20. Radziuk J, Pye S. Quantitation of basal endogenous glucose production in type II diabetes: importance of the volume of distribution. Diabetologia 2002;45:1053-84.
21. 3H-glucose infusion. Diabetologia 1990;33: 603-10.
22. Staehr P, Hojlund K, Hother-Nielsen O, et al. Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in type 2 diabetes? Diabet Med 2003;20:816-22.
23. Basu A, Basu R, Shah P, et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 2000;49:272-83.
24. Basu A, Basu R, Shah P, et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 2001;50:1351-62.
25. Mithieux G, Bady I, Gautier A, et al. Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. Am J Physiol 2004;286:E370-5.
26. Basu A, Alzaid A, Dinneen S, et al. Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest 1996;97: 2351-61.
27. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990;322:223-8.
28. DeFronzo RA, Gunnarsson R, Björkman O, et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 1985;76:149-55.
29. Turk D, Alzaid A, Dinneen S, et al. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 1995;95:755-62.
30. Mandarino LJ, Printz RL, Cusi KA, et al. Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. Am J Physiol 1995;269:E701-8.
31. Nielsen MF, Wise S, Dinneen SF, et al. Assessment of hepatic sensitivity to glucagon in NIDDM. Diabetes 1997;46: 2007-16.
32. Shah P, Basu A, Basu R, Rizza RA. Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol 1999;277:E283-90.
33. Nielsen MF, Basu R, Wise S, et al. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 1998;47:1735-47.
34. Mevorach M, Giacca A, Aharon Y, et al. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 1998;102:744-53.
35. Hawkins M, Gabriely H, Wozniak R, et al. Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes 2002;51:2179-89.